Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Huang L, Liu P, Chen Q, Hu K, Li S, Lee A, Wabitsch M, Zhu LJ, Yu Q, Davis R, Czech MP, Wolfe SA, Wang YX. Adissp activates insulin-independent glucose disposal and energy expenditure in white fat to treat diabetes and cardiometabolic disease. Sci Adv. 2026 Apr 24; 12(17):eaed2780.
-
Karunakaran AC, Bakshi M, Rajendrakumar AM, Wilson-Welder JH, Aroian RV, Schwarz EM, Homan EJ, Ostroff GR, Beshah E, Miramontes E, Papadopoulos MD, Bowdridge SA, Zarlenga DS, Zhu X, Tuo W. Catalytically Active Recombinant Cysteine Proteases of Haemonchus contortus: Their Ability to Degrade Host Blood Proteins and Modulate Coagulation. Int J Mol Sci. 2025 Dec 16; 26(24).
-
Dos Santos NSA, de Almeida-J?nior CR, Ricci MF, Sanches RCO, Fernandes RS, Burle-Caldas GA, de Castro JT, Reis-Cunha JL, Bartholomeu DC, Meira ACM, Nascimento TG, Oliveira NFM, Gazzinelli RT, Machado FS, Teixeira SMR. RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response. Front Cell Infect Microbiol. 2025; 15:1681807.
-
Lopes TB, Coelho FF, Roca TP, Oliveira JKA, Delagarde V, Brichler S, G?mez Mendoza DP, Villalobos Salcedo JM, Vieira DS, Le Gal F, Gazzinelli RT, Fernandes AP. A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. J Clin Microbiol. 2025 May 14; 63(5):e0199924.
-
Ravi S, Sharma T, Yip M, Yang H, Xie J, Gao G, Tai PWL. A deep learning model trained on expressed transcripts across different tissue types reveals cell-type codon-optimization preferences. Nucleic Acids Res. 2025 Mar 20; 53(6).
-
Pardhe BD, Park H, Paudel P, Jeong J, Oh TJ, Choi KY, Ahn J. In-vitro optimization and active-site mutagenesis of CYP105D18 peroxygenase enhance the production of indigo. Enzyme Microb Technol. 2025 Jun; 187:110634.
-
Console L, Tolomeo M, Travo L, Giudice D, Nisco A, Barile M, Indiveri C. Production of the recombinant human riboflavin transporters SLC52A1, 3 and functional assay in proteoliposomes. Arch Biochem Biophys. 2025 04; 766:110327.
-
Xiao H, Meng X, Li Z, Fang S, Wang Y, Li J, Tang J, Ma L. Combined drug anti-deep vein thrombosis therapy based on platelet membrane biomimetic targeting nanotechnology. Biomaterials. 2024 Dec; 311:122670.
-
Bendapudi PK, Foy BH, Mueller SB, Liu J, Feingold LM, Burke KE, Cruz W, Chen MY, Lau ES, Goldberg RL, Tatake I, Wilkinson SC, Carney BJ, Stone JR, Park D, Avelino AR, Hassan S, Andrzejewski C, Ruby KN, Friedman KD, Brunker PAR, Leaf RK, Higgins J, Dzik WH, Stefely JA, Makar RS. Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2024 05 09; 390(18):1690-1698.
-
Sukumaran M, Cantrell DR, D'Agostino C, Jahromi BS, Ansari SA, Potts MB. Bivalirudin as a substitute for heparin in neurointervention for patients with heparin-induced thrombocytopenia. J Stroke Cerebrovasc Dis. 2024 Jun; 33(6):107310.